Indeed, GH may mediate its protective effect in the pathogenesis of NASH by regulating lipogenesis pathways, while IGF-1 has the same effect by regulating cholesterol transport. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatohepatitis.